Apollo Hospitals expands air ambulance services offerings
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The investigational new drug application with FDA was actually for NEOK002, an EGFR/MUC1-targeting antibody-drug conjugate aimed at solid tumors
The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The decision is based on the phase 3 DESTINY-Breast11 trial
The new assay consolidates screening for four major viral threats into a single workflow
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
The inspection is now closed, and no regulatory action has been recommended
Subscribe To Our Newsletter & Stay Updated